GlassScriptPrepare for your visit
Chizelle Onochie
Psychiatry · Houston, TX · NPI 1750841409
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,830.44
in general payments reported to CMS, 2019-2025 · $535 in 2025
The $535 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $775.85
- E.R. Squibb & Sons, L.L.C. $455.64
- Vanda Pharmaceuticals INC. $383.06
- Otsuka America Pharmaceutical, INC. $365.69
- Neurocrine Biosciences, INC. $236.80
- Teva Pharmaceuticals USA, INC. $216.80
Drugs and devices associated with these payments
Vraylar Cobenfy Fanapt Ingrezza Rexulti Austedo Xr Auvelity Caplyta Spravato Tempus Pixel Invega Abilify Maintena
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Chizelle Onochie listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11442192/chizelle-onochie